e Ziplex System. There is a great deal of interest in
focused content - and there are few competitive alternatives. We expect to
have a variety of condition- or pathway-specific Signature Chips that will
be available both as catalog products and through Xceed's Expression
Services. The Metabolic Signature Chip, designed to investigate
differential expression associated with diseases of the metabolic system
(e.g. muscle disorders, obesity, and other metabolic diseases), is
available today. In addition, Xceed now offers the Breast and Colon Cancer
Signature Chips. We have a number of other Signature Chips in development
for inflammation and for a range of cancers, including prostate, lung, and
melanoma. We are actively pursuing licensing arrangements with strategic
partners to add other signatures to our pipeline."
The list price for the Ziplex Automated Workstation, which automates
the hybridization, imaging, quantitation, and quality control, is $85,000
USD. The TipChip consumable that contains assay-specific content can cost
as little as $120 USD per TipChip. (The price will vary based on content.)
As part of the AMP launch, Xceed is offering special promotional pricing
for early adopters.
Technical Topics Workshop
Xceed is also sponsoring a Technical Topics Workshop at the conference:
Translational Research of Gene-Expression Assays to the Ziplex Automated
Workstation by David Englert, PhD. Time: 1 to 2 pm, Wed, Nov 7, 2007, Hyatt
Regency Century Plaza Hotel Constellation Room A.
About Xceed Molecular
Xceed's vision is to advance molecular diagnostics by successfully
translating novel multiplex tests into routine clinical practice and to
create robust diagnostic solutions to improve disease outcomes. Our
products comprise the Ziplex(R) System for automated gene-expression
analysis (available in the US and Canada for research use only), gene
expression services, and pre- configured arrays. Xceed is also developing
multiplexed genomic t
'/>"/>
SOURCE Xceed Molecular Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
AdvaMed 2007 Exceeds Attendance Expectations With More Than 1,100 Participants from 35 States and 25 Countries2.
Xceed Molecular Names Fran Tuttle to Its Board of Trustees3.
A new molecular zip code, and a new drug target for Huntingtons disease4.
New knock-out gene model provides molecular clues to breast cancer5.
Molecular probe paints cancer cells in living animals, Stanford researchers find6.
Story ideas from molecular & cellular proteomics7.
SNM seeks novel approaches to molecular imaging to showcase at annual meeting8.
SNM seeks novel approaches to molecular imaging to showcase at annual meeting9.
Molecular fingerprint of breast-cancer drug resistance can predict response to treatment10.
Molecular profiling can accurately predict survival in colon cancer patients11.
Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative